Adeline Yeo

A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin

Suzanne F. Jones, H. Burris, J. Infante, 2015, Investigational New Drugs.

Effect of Exenatide on the Steady‐State Pharmacokinetics of Digoxin

P. Kothare, K. Mace, H. Linnebjerg, 2005, Journal of clinical pharmacology.